Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment
2017 ◽
Vol 58
(1)
◽
pp. 48-56
◽
2013 ◽
Vol 52
(5)
◽
pp. 347-358
◽
2017 ◽
Vol 121
(4)
◽
pp. 225-233
◽
1998 ◽
Vol 31
(2)
◽
pp. 33A
2010 ◽
Vol 24
(9)
◽
pp. 749-758
◽
2001 ◽
Vol 19
(11)
◽
pp. 2087-2095
◽
1992 ◽
Vol 106
(3)
◽
pp. 665-671
◽